browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
dfecbcb0-aa83-4fa6-af20-cac24868ffe3
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 12:56:16
Income (reported)
Expenses (reported)
$320,000
Expenses method
A
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

OURARING INC.

Contact
WALTER KUHN
Phone
+1 202-640-1892
Address
zip:94108, city:San Francisco, state:CA, street:222 Kearny Street, 7th Floor

Client

OURARING INC.

Health technology.

State
CA
Country
US
Effective date
2025-05-22

Issues lobbied + lobbyists

HCR — Health Issues

Issues related to regulation of health technology. Issues related to insurance coverage of health technology.

Lobbyists:

Government entities lobbied: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

CPT — Copyright/Patent/Trademark

Issues related to enforcement of intellectual property rights.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

DEF — Defense

Issues related to human performance technology.

Lobbyists:

Government entities lobbied: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE

TAX — Taxation/Internal Revenue Code

Issues related to tax benefits for health technology.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HOM — Homeland Security

Issues related to human performance technology.

Lobbyists:

Government entities lobbied: Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; SENATE; Transportation Security Administration (TSA); U.S. Coast Guard (USCG); U.S. Customs & Border Protection; U.S. Immigration & Customs Enforcement (ICE); U.S. Secret Service

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.